177 related articles for article (PubMed ID: 11306963)
1. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN;
Int Arch Allergy Immunol; 2001; 124(1-3):183-6. PubMed ID: 11306963
[TBL] [Abstract][Full Text] [Related]
2. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN
Am J Respir Crit Care Med; 2000 Jul; 162(1):75-80. PubMed ID: 10903223
[TBL] [Abstract][Full Text] [Related]
3. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
Wechsler ME; Kunselman SJ; Chinchilli VM; Bleecker E; Boushey HA; Calhoun WJ; Ameredes BT; Castro M; Craig TJ; Denlinger L; Fahy JV; Jarjour N; Kazani S; Kim S; Kraft M; Lazarus SC; Lemanske RF; Markezich A; Martin RJ; Permaul P; Peters SP; Ramsdell J; Sorkness CA; Sutherland ER; Szefler SJ; Walter MJ; Wasserman SI; Israel E;
Lancet; 2009 Nov; 374(9703):1754-64. PubMed ID: 19932356
[TBL] [Abstract][Full Text] [Related]
4. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.
Israel E; Chinchilli VM; Ford JG; Boushey HA; Cherniack R; Craig TJ; Deykin A; Fagan JK; Fahy JV; Fish J; Kraft M; Kunselman SJ; Lazarus SC; Lemanske RF; Liggett SB; Martin RJ; Mitra N; Peters SP; Silverman E; Sorkness CA; Szefler SJ; Wechsler ME; Weiss ST; Drazen JM;
Lancet; 2004 Oct 23-29; 364(9444):1505-12. PubMed ID: 15500895
[TBL] [Abstract][Full Text] [Related]
5. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations.
Carroll CL; Stoltz P; Schramm CM; Zucker AR
Chest; 2009 May; 135(5):1186-1192. PubMed ID: 19029431
[TBL] [Abstract][Full Text] [Related]
6. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
[TBL] [Abstract][Full Text] [Related]
7. beta-Adrenergic receptor polymorphisms and response to salmeterol.
Wechsler ME; Lehman E; Lazarus SC; Lemanske RF; Boushey HA; Deykin A; Fahy JV; Sorkness CA; Chinchilli VM; Craig TJ; DiMango E; Kraft M; Leone F; Martin RJ; Peters SP; Szefler SJ; Liu W; Israel E;
Am J Respir Crit Care Med; 2006 Mar; 173(5):519-26. PubMed ID: 16322642
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
9. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.
Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HG
Am J Respir Crit Care Med; 2010 Apr; 181(7):676-87. PubMed ID: 19910613
[TBL] [Abstract][Full Text] [Related]
10. Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.
Taylor DR; Drazen JM; Herbison GP; Yandava CN; Hancox RJ; Town GI
Thorax; 2000 Sep; 55(9):762-7. PubMed ID: 10950895
[TBL] [Abstract][Full Text] [Related]
11. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
Bateman ED; Kornmann O; Schmidt P; Pivovarova A; Engel M; Fabbri LM
J Allergy Clin Immunol; 2011 Aug; 128(2):315-22. PubMed ID: 21807250
[TBL] [Abstract][Full Text] [Related]
12. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.
Kukreti R; Bhatnagar P; B-Rao C; Gupta S; Madan B; Das C; Guleria R; Athavale AU; Brahmachari SK; Ghosh B
Pharmacogenomics; 2005 Jun; 6(4):399-410. PubMed ID: 16004558
[TBL] [Abstract][Full Text] [Related]
13. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.
Martinez FD; Graves PE; Baldini M; Solomon S; Erickson R
J Clin Invest; 1997 Dec; 100(12):3184-8. PubMed ID: 9399966
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the β2-adrenergic receptor correlated to nocturnal asthma and the response of terbutaline nebulizer.
Lee MY; Cheng SN; Chen SJ; Huang HL; Wang CC; Fan HC
Pediatr Neonatol; 2011 Feb; 52(1):18-23. PubMed ID: 21385652
[TBL] [Abstract][Full Text] [Related]
15. Influence of β(2)-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol.
Giubergia V; Gravina L; Castaños C; Chertkoff L
Ann Allergy Asthma Immunol; 2013 Mar; 110(3):156-60. PubMed ID: 23548523
[TBL] [Abstract][Full Text] [Related]
16. Influence of beta2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children.
Giubergia V; Gravina LP; Castaños C; Chertkoff L; Grenoville M
Pediatr Pulmonol; 2008 May; 43(5):421-5. PubMed ID: 18383333
[TBL] [Abstract][Full Text] [Related]
17. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network.
Drazen JM; Israel E; Boushey HA; Chinchilli VM; Fahy JV; Fish JE; Lazarus SC; Lemanske RF; Martin RJ; Peters SP; Sorkness C; Szefler SJ
N Engl J Med; 1996 Sep; 335(12):841-7. PubMed ID: 8778601
[TBL] [Abstract][Full Text] [Related]
18. Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma.
Slankard M; Michelis MA; Mansukhani M; McGoey B; Paige A; Andrews H; Lederer D; Canfield S; DiMango E
J Asthma; 2016 Oct; 53(8):783-9. PubMed ID: 27050801
[TBL] [Abstract][Full Text] [Related]
19. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics.
Tan S; Hall IP; Dewar J; Dow E; Lipworth B
Lancet; 1997 Oct; 350(9083):995-9. PubMed ID: 9329515
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of the ADRB2 gene and response to inhaled beta- agonists in children with asthma: a meta-analysis.
Finkelstein Y; Bournissen FG; Hutson JR; Shannon M
J Asthma; 2009 Nov; 46(9):900-5. PubMed ID: 19905915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
